Accéder au contenu
Merck

Chronic exercise improves hepatic acylcarnitine handling.

iScience (2024-02-16)
Diego Hernández-Saavedra, J Matthew Hinkley, Lisa A Baer, Kelsey M Pinckard, Pablo Vidal, Shinsuke Nirengi, Andrea M Brennan, Emily Y Chen, Niven R Narain, Valerie Bussberg, Vladimir V Tolstikov, Michael A Kiebish, Christina Markunas, Olga Ilkayeva, Bret H Goodpaster, Christopher B Newgard, Laurie J Goodyear, Paul M Coen, Kristin I Stanford
RÉSUMÉ

Exercise mediates tissue metabolic function through direct and indirect adaptations to acylcarnitine (AC) metabolism, but the exact mechanisms are unclear. We found that circulating medium-chain acylcarnitines (AC) (C12-C16) are lower in active/endurance trained human subjects compared to sedentary controls, and this is correlated with elevated cardiorespiratory fitness and reduced adiposity. In mice, exercise reduced serum AC and increased liver AC, and this was accompanied by a marked increase in expression of genes involved in hepatic AC metabolism and mitochondrial β-oxidation. Primary hepatocytes from high-fat fed, exercise trained mice had increased basal respiration compared to hepatocytes from high-fat fed sedentary mice, which may be attributed to increased Ca2+ cycling and lipid uptake into mitochondria. The addition of specific medium- and long-chain AC to sedentary hepatocytes increased mitochondrial respiration, mirroring the exercise phenotype. These data indicate that AC redistribution is an exercise-induced mechanism to improve hepatic function and metabolism.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anti-CPT1A Antibody, serum, from rabbit
Sigma-Aldrich
Anti-SLC25A20 antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-CPT1B antibody produced in rabbit, affinity isolated antibody